Search

Search Results
Results 381 - 390 of 604 for Skin Cancer
  • Rukobia Tablets
    Drug - 5 Aug 2021
    Consumer Medicine Information (CMI) about Rukobia Tablets intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Thioprine 50
    Drug - 12 Feb 2020
    Consumer Medicine Information (CMI) about Thioprine 50 (azathioprine film-coated tablets) intended for persons living in Australia.
  • Zedace
    Drug - 11 Dec 2025
    Consumer Medicine Information (CMI) about Zedace intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Dapa-Tabs intended for persons living in Australia.
  • Perisyl Combi
    Drug - 9 Dec 2025
    Consumer Medicine Information (CMI) about Perisyl Combi intended for persons living in Australia.
  • Paxlovid
    Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Paxlovid intended for persons living in Australia.
  • Diflucan
    Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Diflucan intended for persons living in Australia.
  • Tranalpha
    Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Tranalpha intended for persons living in Australia.
  • Mersynofen
    Drug - 5 Dec 2025
    Consumer Medicine Information (CMI) about Mersynofen intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback